Date: 2015-04-09
Type of information: Nomination
Compound:
Company: Serodus (Norway)
Therapeutic area: Metabolic diseases - Renal diseases - Kidney diseases
Type agreement: nomination
Action mechanism:
Disease:
Details: * On April 9, 2015, Serodus announced the strengthening of its management team with the employment of Jürgen Langhärig as Vice President, Business Development. Jürgen Langhärig holds a PhD in Industrial Microbiology from the University of Tübingen, Germany and an MBA from St. Gallen University, Switzerland. Jürgen Langhärig brings more than 30 years of international marketing and business development experience to Serodus from positions in Sandoz , Nycomed, Novo Nordisk and Zealand Pharma. Since 2008 Jürgen Langhärig was VP Business Development at Bavarian Nordic where he was instrumental in concluding the two major licensing deals with Big Pharma which have more than tripled Bavarian Nordic’s share price within the last 12 months. Jürgen. Langhärig will be part of a dynamic and focused organization at Serodus and will be part of the Management Team defining the strategy going forward.
Financial terms:
Latest news:
